A new resource allows for studies of human longevity and resilience that can fuel the discovery and validation of novel therapeutics for aging-related disease.
Geiger Mueller News Service
Geiger Mueller News Service
A new resource allows for studies of human longevity and resilience that can fuel the discovery and validation of novel therapeutics for aging-related disease.